Yuanxiang Lin
ORCID: 0000-0001-5803-2644Also affiliated with First Affiliated Hospital of Fujian Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 6 papers. Top paper: “Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study”.
Apeng Yang, Jingke Yang, Sheng Zhang, Zhen Xing, Xingfu Wang +24 more
Ting Xu, Danhong Wang, Meiling Li, Yuanxiang Lin, Franziska Schoeppe +7 more
Louisa Dahmani, Danhong Wang, Jianxun Ren, Sophia Stöcklein, Yuanxiang Lin +10 more
Louisa Dahmani, Jianxun Ren, Lunhao Shen, Xiaomei Peng, Ruiqi Wang +13 more
Hesheng Liu, Ting Xu, Danhong Wang, Meiling Li, Yuanxiang Lin +5 more
Fan Yang, Angcheng Li, Debao Zhao, Nengjun Ma, Linying Chen +10 more